← Evidence map

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.

Pierre Dillard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42800469